MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2008.02.012

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2008

A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy.

Esmore Donald, Kaye David, Spratt Phillip, Larbalestier Robert, Ruygrok Peter, Tsui Steven, Meyers Deborah, Fiane Arnt E, Woodard John

Клиническое исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The increasing prevalence of chronic heart failure has stimulated the ongoing development of left ventricular assist devices (LVADs) for both bridge-to-transplant (BTT) and destination therapy (DT). The aim of this prospective, multicenter clinical trial was to determine the efficacy and safety of a third-generation LVAD, the VentrAssist, in a BTT cohort.

METHODS

Patients (n = 33) with end-stage chronic heart failure who required circulatory support as BTT therapy were implanted with a VentrAssist device. The primary outcome was survival until transplant or transplant eligibility with the device in situ at trial end-point (Day 154 after implant). The secondary outcomes were pump flow index and end-organ function. Safety, patient functional status and resource use were also assessed.

RESULTS

At trial end-point, the success rate was 82% (39.4% transplanted, 42.4% transplant-eligible). The LVAD pump flow index (median >or=2.7 liters/min/m(2)) was sufficient to maintain an adequate circulation and significantly improve end-organ function. Of the 77 protocol-defined serious adverse events, most occurred within 30 days of implantation. No patients died as a direct result of pump failure or malfunction. After implantation, patient functional status improved, with 70% of patients achieving hospital discharge, and resource use was reduced.

CONCLUSIONS

This trial demonstrated a favorable efficacy and safety profile for use of the VentrAssist LVAD in BTT patients.

Для цитирования: Esmore Donald, Kaye David, Spratt Phillip, Larbalestier Robert, Ruygrok Peter, Tsui Steven, Meyers Deborah, Fiane Arnt E, Woodard John. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2008. DOI: 10.1016/j.healun.2008.02.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.